What is GEVO's health score?

Gevo, Inc. (GEVO) has a TradeApes health score of 41 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GEVO's estimated fair value?

Based on our 5-year discounted cash flow model, Gevo, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is GEVO undervalued or overvalued?

Our model currently rates GEVO as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for GEVO... Refresh in a moment for the full analysis.

Gevo, Inc. (GEVO)

Materials Inconclusive inconclusive weak

$1.7

Updated: 2026-06-05

TradeApes Score

Financial Strength

5 Stressed

Operating Trend

65 Healthy

Relative Value

40 Weak

Capital Allocation

45 Mixed

Risk

70 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.